bioRxiv Science⌕ Search

bioRxiv · 10.1101/2024.08.29.610247

Global brain asymmetry and its variations in aging and related diseases

Abstract

Functional lateralization is a cardinal feature of human brain, and deviations from typical lateralization are observed in various brain disorders. Although this phenomenon has been widely acknowledged in the field of human neuroscience, decades of research have shown that it is a challenge to bridge the gap between (a)typically lateralized functions and hemispheric differences in structure (termed structural asymmetry). To address this important question, the present study employed the state-of-the-art machine learning techniques to investigate the brain structural asymmetry and its associations with cognitive functions, aging, and aging-related diseases, by integrating large-scale datasets. Our proposed multivariate approach revealed previously unknown and substantial structural differences between the left and right hemispheres, and established the associations between the global brain asymmetry and lateralized functions including hand motor and emotion processing. Furthermore, at the population level we mapped the aging trajectories of the global brain asymmetry, and unveiled significant diagnosis-specific variations in patients with Alzheimers disease and Parkinsons disease, and individuals carrying a relevant genetic risk for atypical brain aging (i.e., APOE4 carriers). These results demonstrated left-hemisphere-linked changes in aging, which has challenged the traditional "right hemi-aging" model, and offered a promising approach for assessing brain aging and related diseases. Overall, our study with a novel approach presents one of the largest-scale investigation of global brain asymmetry, and takes an important step forward in understanding the intricate interplay between structural asymmetry, lateralized functions, and brain aging in health and disease. Significance statementFunctional lateralization is fundamental to the human brain, with deviations linked to various brain disorders. Bridging the gap between functional lateralization and structural asymmetry has been a long-standing challenge. Using advanced machine learning and large-scale datasets, this study introduced a multivariate global brain asymmetry approach and revealed previously unidentified structural differences between the brain hemispheres, correlating these with cognitive functions, aging, and diseases like Alzheimers and Parkinsons. Contrary to the traditional "right hemi-aging" model, we found left-hemisphere-linked aging changes. This work provides new insights into brain asymmetry, lateralized functions, and aging, offering a promising approach for assessing brain health and disease. Classifications: Biological Sciences (Psychological and Cognitive Sciences);

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hu, H., Pu, Y., Abuduaini, Y., Wang, X., Francks, C., Thompson, P. M., Kong, X.-Z.. 2024-08-30. Global brain asymmetry and its variations in aging and related diseases. https://doi.org/10.1101/2024.08.29.610247

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗